BUZZ-West Pharmaceuticals rises after upbeat 2026 profit forecast
Reuters
Yesterday
BUZZ-West Pharmaceuticals rises after upbeat 2026 profit forecast
** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 5.52% to $259.74 premarket
** WST forecasts 2026 adjusted profit per share of $7.85 to $8.20, above analysts' estimates of $7.78 - LSEG data
** Co expects annual revenue to be between $3.22 billion and $3.28 billion, vs. estimates of $3.25 billion
** Q4 revenue stood at $805 million, above estimates of $794.38 million
** WST stock fell 16% in 2025
(Reporting by Gnaneshwar Rajan in Bengaluru)
((Gnaneshwar.Rajan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.